Navigation Links
Abbott to Present Data on Market-Leading XIENCE V® and Promising Vascular Pipeline at TCT 2010
Date:9/16/2010

rk in March 2008. In the U.S., the MitraClip system is limited by federal law to investigational use only and is not available for sale. The MitraClip system is currently under review for approval by the U.S. Food and Drug Administration.

ABSORB: Nine-month data on 45 patients and six-month data on all 101 patients from the second phase of ABSORB will be presented on Wednesday, Sept. 22. The ABSORB trial is evaluating Abbott's bioresorbable vascular scaffold (BVS), which aims to restore blood flow by opening a clogged vessel and providing support until it is healed. Once the vessel can remain open without the extra support, the BVS is designed to be slowly metabolized and eventually resorbed by the body. Abbott's BVS device is under clinical investigation outside the U.S. The device is currently in development at Abbott Vascular and not available for sale.

As part of its commitment to ongoing medical education, Abbott is providing support for a number of symposia on key topics for interventional cardiologists throughout the conference. In addition, the Abbott booth (#1456) will feature the company's vascular pipeline, as well as resources and programs for physicians and patients.

About XIENCE VAbbott's market-leading XIENCE V drug eluting stent is marketed in the U.S., Europe, Japan and other international markets.

Everolimus, developed by Novartis Pharma AG, is a proliferation signal inhibitor, or mTOR inhibitor, licensed to Abbott by Novartis for use on its drug eluting stents. Everolimus has been shown to inhibit in-stent neointimal growth in the coronary vessels following stent implantation, due to its anti-proliferative properties.

XIENCE V is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (lesions less than or equal to 28 mm) with reference vessel diameters of 2.5 mm to 4.25 mm. Additional information about XIENCE V,
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Mass. , May 20, 2013 ... and advisory firms for pharmaceutical and healthcare issues, ... that therapies offering a greater effect on quality ... unmet need. Given the high level of subjectivity ... of life, interviewed thought leaders state that it ...
(Date:5/19/2013)... 2013  The non-surgical Stretta® procedure ... energy is effective in control of gastroesophageal reflux ... for medication 10 years post-procedure, according to an ... Digestive Disease Week (DDW) meeting May 18-21, 2013 ... "The sustained improvement in GERD-HRQL scores ...
(Date:5/17/2013)... May 17, 2013 The power of plants ... ways in which mankind depends on the plant kingdom, ... multifaceted exhibition Wild Medicine: Healing Plants ... on view from May 18 through September 8, 2013. ... The featured exhibition,s many attractions include a re-creation of ...
Breaking Medicine Technology:For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2
(Date:5/20/2013)... 6Webs.com is the leading supplier of unbiased ... recently completed their assessments of the top alarm system ... and the top home security system companies are ranked ... equipment and warranties to mention a few. , ... completed the home security reviews, numerous people claimed that ...
(Date:5/20/2013)... Selexis SA, a serial innovation company ... line development for scale-up and manufacturing of therapeutic protein ... data on the Company’s core technology at the 2013 ... 20 - 23 at the Hyatt Regency La Jolla ... scientific advisory board member, Nicolas Mermod, PhD, Professor of ...
(Date:5/20/2013)... A new Canadian study has uncovered an apparent gender ... than men to get trauma center care following a ... care services in general have been recognized for some ... to the treatment of severe injuries in trauma centers," ... Health Sciences Centre and the University of Toronto, said ...
(Date:5/20/2013)... Texas (PRWEB) May 20, 2013 ... Phytel, the leader in automated, provider-led population health ... systems to effect change and successfully pursue population ... advisory services and technology to accelerate the transition ... the VHA IMPERATIVTM performance improvement suite of services, ...
(Date:5/20/2013)... between use of anabolic-androgenic steroids and reduced mental health ... a new study on elite male strength athletes that ... the British Journal of Sports Medicine . Twenty ... steroid use. , The study is published by ... education and research on addiction. Together with colleagues from ...
Breaking Medicine News(10 mins):Health News:Best Home Alarm System Companies in 2013 Published by Leading Security Reviews Site - 6Webs.com 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 3Health News:Women Less Likely to Get Trauma Center Care After Injury: Study 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4
... Ambo ... Year category for the 2010 Frank G. Berlin, Sr. Small Business of the Year Awards presented ... contains as much omega-3 fish oil as a filet of salmon. , ... Venice, FL (PRWEB) April 27, 2010 -- Ambo Foods, LLC, maker ...
... needed, researchers suggest , TUESDAY, April 27 (HealthDay News) -- ... chronic kidney disease have more severe anemia than white patients, ... low levels of red blood cells, is diagnosed by measuring ... out of red blood cells. In general, hemoglobin levels below ...
... ... baby blankets brings personalization to the one gift event where personalization has been impossible. ,Ensure ... as it is memorable. , ... (PRWEB) April 27, 2010 -- Fill In The Blankie provides the solution to presenting a ...
... disease, researchers at Mount Sinai School of Medicine have found ... brain, rather than the amyloid plaques previously thought by many ... which was supported by the "Oligomer Research Consortium" of the ... Administration, appears in the journal Annals of Neurology . ...
... , ... Latest Free, Easy to Use, Yet Extremely Powerful Tool Designed for System Administrators and Application ... ... VKernel , the award winning provider of capacity management products for virtualized datacenters announced ...
... ... allergy elimination as opposed to allergy prevention. Absolute Health is a unique healthcare facility ... symptoms caused by allergies that actually quell allergies as opposed to simply preventing them. ... Scottsdale, AZ ...
Cached Medicine News:Health News:Omega-3 Cookie Company Recognized as Finalist for Prestigious Business Award 2Health News:Anemia Harder to Treat in Black Children With Kidney Disease 2Health News:Myth Debunked: Baby Shower Gifts CAN Be Personalized Without Knowing Name Or Gender 2Health News:Myth Debunked: Baby Shower Gifts CAN Be Personalized Without Knowing Name Or Gender 3Health News:Alzheimer's memory problems originate with protein clumps floating in the brain, not amyloid plaques 2Health News:New VKernel AppVIEW 1.0 for Monitoring and Identification of Capacity Bottlenecks in Critical Application VMs 2Health News:Allergy Treatment from Absolute Health Provides Allergy Elimination as Opposed to Allergy Prevention 2Health News:Allergy Treatment from Absolute Health Provides Allergy Elimination as Opposed to Allergy Prevention 3
Provides secure fracture immobilization while allowing for full range of motion at elbow and wrist...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... 3-Point® Polycentric Hinged Ulnar Deviation Splint ... align the hand with ulnar deviation at ... impede grasp or pinch. Radial and ulnar ... ensure unimpeded flexion and extension. Padded, malleable ...
... Orthosis For quick, efficient immobilization of ... immobilizes and protects the fracture and ... comfort, support, and conformity to the ... shell may be gently heated (with ...
Medicine Products: